Search results
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
KFGO· 4 days agoBy Sam Tobin LONDON (Reuters) - Pfizer and BioNTech asked a London court to revoke rival Moderna's...
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National...
Digital Journal· 5 days ago(NASDAQ:MRNA) today announced a contract with the Ministry of Health in Brazil (Ministério da Saúde) to supply its mRNA COVID-19 vaccine
...Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 3 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
AstraZeneca confirms strong vaccine protection after US rift
AOL· 3 days agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
X’s Community Notes Accurately Corrected Vaccine Misinformation 97% Of The Time Last Year, Study...
Forbes· 3 days agoThe relatively new community notes feature on X, formerly known as Twitter, almost always featured...
Some 700,000 Brits To Get Free Covid-19 Booster Shots This Week
Forbes· 6 days agoStarting Monday, the elderly and those with weakened immune systems will be able to get a shot free...
COVID may have eroded doctors' belief that they are obligated to treat infectious patients
Center for Infectious Disease Research and Policy· 1 day agoA systematic review posted in Clinical Infectious Diseases reveals that, amid the COVID-19 pandemic,...
GSK Sues Pfizer, BioNTech for Share of Billions in Vaccine Sales
Bloomberg Law· 2 days agohave reported from sales of their Covid-19 vaccines, which GSK alleges infringe five patents related to mRNA vaccine
Navigating Vaccine Coverage for Seniors With Medicare Changes | ThinkAdvisor
ThinkAdvisor· 1 day agoThe COVID vaccine is just one of many that clients might want.
No, Marburg Virus Isn't in COVID Shots: Users Debunk Vax Misinfo on X
MedPage Today· 3 days agoThe Community Notes feature, an open-source misinformation countermeasure introduced to X (formerly Twitter) in 2022, was successful in correcting COVID-19